Legal & General Group
KMTS

Legal & General Group’s Kestra Medical Technologies KMTS Stock Holding History

Legal & General Group’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
14,374
+1,548
+12% +$32.4K ﹤0.01% 2467
2026
Q1 		$256K Sell
12,826
-1,760
-12% -$41.5K ﹤0.01% 2496
2025
Q4 		$387K Buy
14,586
+13,152
+917% +$339K ﹤0.01% 2483
2025
Q3 		$34K Hold
1,434
– – ﹤0.01% 2830
2025
Q2 		$23.8K Buy
1,434
+434
+43% +$9.47K ﹤0.01% 2939
2025
Q1 		$24.9K Buy
+1,000
New +$23K ﹤0.01% 2873

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Legal & General Group's KMTS Position: Q2 2026 in Review

Legal & General Group increased its Kestra Medical Technologies (KMTS) stake by 12% in Q2 2026, buying an estimated $32.4K and bringing the position to 14,374 shares worth $366K. The position accounts for ﹤0.01% of the portfolio, ranked #2467.

Legal & General Group first reported a position in KMTS in Q1 2025 and has held it in 6 quarters since. The position peaked at $387K in Q4 2025. 108 funds tracked by Wall St. Rank hold KMTS as of Q2 2026.

  • Legal & General Group held 14,374 shares of Kestra Medical Technologies worth $366K as of Q2 2026.
  • Legal & General Group bought 1,548 Kestra Medical Technologies shares in Q2 2026, an estimated $32.4K.
  • Kestra Medical Technologies made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2467 holding.
  • Legal & General Group first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 6 quarters since.
  • Legal & General Group's Kestra Medical Technologies position peaked at $387K in Q4 2025.
  • 108 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.